Marc Stapley - Mar 3, 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role: Chief Executive Officer, Director
Signature: /s/ Jane Alley as attorney-in-fact
Stock symbol: VCYT
Transactions as of: Mar 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/7/2022, 03:37 PM
Previous filing: Jan 5, 2022
Next filing: Jun 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCYT	Common Stock	Award	$0	+56.5K	+119.6%	$0.00	104K	Mar 3, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCYT	Stock Option (right to buy)	Award	$0	+103K		$0.00	103K	Mar 3, 2022	Common Stock	103K	$26.02	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2	Includes 464 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2022.
F3	The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.